Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
IntriCon Corporation

IntriCon Corporation (IIN) Stock Overview

Explore IntriCon Corporation’s financial performance, market position, analyst ratings, and future outlook.

IIN●NASDAQ
HealthcareMedical - Instruments & Supplies
$24.23
$0.03(0.12%)
U.S. Market opens in 14h 26m

IntriCon Corporation (IIN)

Meyka AI Score

Z

Key Financials

Market Cap0
P/E Ratio-3461.43
EPS (TTM)$0.11
ROE-0.00%
Fundamental Analysis

AI Price Forecasts

1 Month$21.43
3 Months$22.65
1 Year Target$32.27

IIN Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of IntriCon Corporation (NASDAQ: IIN) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, IntriCon Corporation's NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of IIN on the NASDAQ shows an RSI of N/A, suggesting the stock is in a an undetermined condition. Our forecasting models predict a 12-month price target of $32.27 for the NASDAQ listing.

Key metrics behind IntriCon Corporation's NASDAQ-traded stock include a P/E ratio of -3461.43 and a market capitalization of 0. Combined with our AI analysis, these give both institutional and retail investors a clear view of IIN on the NASDAQ.

Price Performance (NASDAQ: IIN)

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
N/A
6-Month Change
N/A
Year-to-Date (YTD) Change
N/A
1-Year Change
N/A
3-Year Change
-0.04%
5-Year Change
66.99%
All-Time (Max) Change
1111.50%

Contact Information

https://www.intricon.com
16516369770
1260 Red Fox Road, Arden Hills, MN, 55112

Company Facts

8,730 Employees
IPO DateMar 17, 1980
CountryUS

Frequently Asked Questions